Bio-implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Bio-implants market is segmented by Type of Bio-implants (Cardiovascular Implants, Spinal implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants, and Other Implants), Origin, and Geography

Market Snapshot

Bio-implants Market 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The bio-implants market is primarily driven by the rising burden of chronic diseases and lifestyle-related disorders. Bio-implants help in better management and specific drug delivery in conditions, such as obesity, infections, and musculoskeletal disorders. For instance, bio-implants provide a unique and specific drug delivery for the skeletal system.

  • In the case of chronic osteomyelitis and deep soft-tissue infections, beads and spacers with high antibiotic concentrations are used for treatment, as they help in eliminating systemic side effects. According to the American Heart Association (AHA), cardiovascular diseases account for 17.3 million deaths per year. The Centre for Disease Control and Prevention states that heart diseases account for 610,000 deaths per year in the United States.
  • In the European region, cardiovascular disease (CVD) causes more than half of the total deaths. In Europe, CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis, and malaria combined. Apart from cardiovascular diseases, there are several high number of patient cases admitted in hospitals related to orthopedic, spinal, and dental injuries, where the bio-implants become a useful option for doctors and families alike to patients. Hence, the market studied is expected to witness a steady growth over the forecast period.

Scope of the Report

A bio-implant is a prosthesis that is used to normalize physiological functions. It is made of biosynthetic materials, like collagen, and tissue-engineered products, like artificial skin and tissues. Some of the bioimplants are made up of polymers or biopolymers as well. The market is segmented by type of bio-implants, origin, and geography.

By Type of Bio-implants
Cardiovascular Implants
Spinal implants
Orthopedic Implants
Dental Implants
Ophthalmic Implants
Other Implants
By Material
Biomaterial Metal and Alloys
Polymers
Other Materials
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Cardiovascular Implants Segment is Expected to Hold the Largest Share

The major factor driving the growth of the market is the rising prevalence of cardiovascular diseases across the world. Moreover, there is an evident rise in geriatric population, globally, which is expected to create more opportunities for the market over the forecast period. As per the data published by the Pennsylvania Health Care Cost Containment Council, congenital heart defect affects nearly one out of every 100 infants in the United States or about 40,000 children per year. Furthermore, according to the estimates of the American Heart Association, in 2018, cardiovascular diseases accounted for nearly 836,546 deaths in the United States, which is about 1 of every three deaths in the country. Also, some of the significant risk factors, such as smoking and high blood pressure, are increasing in the United States owing to the sedentary lifestyle of the population. Most of the patients opt for heart surgery, and bioimplants can be used to treat various cardiovascular diseases. Thus, owing to all the above-mentioned factors, the market is expected to witness high growth over the forecast period.

Number of Deaths due to Cardiovascular diseases (Millions)

North America is Expected to Account for the Largest Market Share

North America is found to hold a major share of the bio-implants market and is expected to show a similar trend over the forecast period, without significant fluctuations. The major factors driving the growth of the market are the increasing prevalence of chronic diseases and the presence of better healthcare infrastructure. According to the American Chiropractic Association, 2017, about 65 million Americans are suffering from lower back problems every year, and approximately 8 out of every 10 Americans are expected to suffer from back pain at some point in their life. In addition, there are rising number of cases of ophthalmic diseases in the United States. For instance, according to the National Eye Institute, about 7.7 million diabetic retinopathy cases and 24 million cataract cases were recorded in the country. This number is expected to reach 11.3 million and 38 million, respectively, by 2030. The rising number of cases of chronic diseases is expected to increase the overall demand in the bio-implants market. Thus, owing to the all above mentioned factors, the market is expected to witness a high growth rate over the forecast period.

Bio-implants_Geography

Competitive Landscape

The market studied is consolidated, owing to the presence of a few key players. The major market players are focusing on technological advancement to acquire the maximum market share. Some of the market players are Implantate AG, Abbott, Bausch & Lomb Incorporated, BIOTRONIK Inc., Edwards Lifesciences Corporation, LifeNet Health, MiMedx, Smith & Nephew PLC, and Zimmer Biomet.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Chronic Diseases and Lifestyle Disorders

      2. 4.2.2 Rising Preference toward Minimally Invasive Surgeries

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Bio-implants

      2. 4.3.2 Unfavorable Reimbursement Policies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Bio-implants

      1. 5.1.1 Cardiovascular Implants

      2. 5.1.2 Spinal implants

      3. 5.1.3 Orthopedic Implants

      4. 5.1.4 Dental Implants

      5. 5.1.5 Ophthalmic Implants

      6. 5.1.6 Other Implants

    2. 5.2 By Material

      1. 5.2.1 Biomaterial Metal and Alloys

      2. 5.2.2 Polymers

      3. 5.2.3 Other Materials

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 aap Implantate AG

      2. 6.1.2 Abbott

      3. 6.1.3 Bausch & Lomb Incorporated

      4. 6.1.4 BIOTRONIK Inc.

      5. 6.1.5 Edwards Lifesciences Corporation

      6. 6.1.6 LifeNet Health

      7. 6.1.7 MiMedx

      8. 6.1.8 Smith & Nephew PLC

      9. 6.1.9 Zimmer Biomet

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Bio-implants Market market is studied from 2018 - 2026.

The Bio-implants Market is growing at a CAGR of 8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

aap Implantate AG, BIOTRONIK, Inc., Edwards Lifesciences Corporation, ZimmerBiomet, Smith & Nephew Plc are the major companies operating in Bio-implants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!